Recruitment

Recruitment Status
Completed
Estimated Enrollment
200

Inclusion Criterias

Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
Eight (8) headache days per month for at least 1 of the preceding 15 months
Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
Eight (8) headache days per month for at least 1 of the preceding 15 months

Exclusion Criterias

Not currently diagnosed with chronic migraine, headache or migraine
History of receiving botulinum toxin injections for the treatment of chronic migraine.
Not currently diagnosed with chronic migraine, headache or migraine
History of receiving botulinum toxin injections for the treatment of chronic migraine.

Summary

Conditions
  • Headache
  • Migraine Disorders
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Retrospective

Participation Requirements

Age
Between 18 years and 65 years
Gender
Both males and females

Inclusion Criterias

Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
Eight (8) headache days per month for at least 1 of the preceding 15 months
Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
Eight (8) headache days per month for at least 1 of the preceding 15 months

Exclusion Criterias

Not currently diagnosed with chronic migraine, headache or migraine
History of receiving botulinum toxin injections for the treatment of chronic migraine.
Not currently diagnosed with chronic migraine, headache or migraine
History of receiving botulinum toxin injections for the treatment of chronic migraine.

Locations

Raleigh, North Carolina
Raleigh, North Carolina

Tracking Information

NCT #
NCT01946126
Collaborators
Not Provided
Investigators
Study Director: Medical Director Allergan